Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 26, 1998New England Journal of MedicineOpen Access

Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura

View Full Paper
Ask AI
Bookmark
Share

Authors

HTHan‐Mou TsaiState University of New YorkELEric Chun‐Yet LianUniversity of Miami

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tsai et al. (1998) studied this question.

synapsesocial.com/papers/6a74492f2ea79cdc4d61ae76https://doi.org/10.1056/nejm199811263392203
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome1998 · 1,674 citations
  2. 2Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells1982 · 127 citations
  3. 3Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura1991 · 1,940 citations
  4. 4von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene [published erratum appears in Blood 1995 Sep 15;86(6):2461]1994 · 42 citations